Conversely, a reduction or downregulation in several components of the NLRP3 inflammasome has been implicated in the pathogenesis of hepatocellular carcinoma, chemically induced squamous cell carcinoma, primary melanoma, and colitis-associated cancer [240,241,242,243]. The gene discussed is NLRP3; the disease is melanoma.